Divalent 2-(4-Hydroxyphenyl)benzothiazole Bifunctional Chelators for 64Cu Positron Emission Tomography Imaging in Alzheimer's Disease

Inorg Chem. 2022 Dec 19;61(50):20326-20336. doi: 10.1021/acs.inorgchem.2c02740. Epub 2022 Dec 4.

Abstract

Herein, we report a new series of divalent 2-(4-hydroxyphenyl)benzothiazole bifunctional chelators (BFCs) with high affinity for amyloid β aggregates and favorable lipophilicity for blood-brain barrier penetration. The addition of an alkyl carboxylate ester pendant arm offers high binding affinity toward Cu(II). The novel BFCs form stable 64Cu-radiolabeled complexes and exhibit promising partition coefficient (logD) values of 1.05-1.85. Among the five compounds tested, the 64Cu-YW-15 complex exhibits significant staining of amyloid β plaques in ex vivo autoradiography studies. In addition, biodistribution studies show that 64Cu-YW-15-Me exhibits moderate brain uptake (0.69 ± 0.08 %ID/g) in wild type mice.

MeSH terms

  • Alzheimer Disease* / diagnostic imaging
  • Alzheimer Disease* / metabolism
  • Amyloid beta-Peptides / chemistry
  • Animals
  • Benzothiazoles / chemistry
  • Benzothiazoles / pharmacokinetics
  • Chelating Agents* / chemistry
  • Mice
  • Plaque, Amyloid / diagnostic imaging
  • Positron-Emission Tomography* / methods
  • Tissue Distribution

Substances

  • Amyloid beta-Peptides
  • Benzothiazoles
  • Chelating Agents
  • 2-(4-hydroxyphenyl)benzothiazole